Vidcast: https://www.instagram.com/p/DZ10DVMBSUf/

For the first time in 20 years, the FDA has approved a new active sunscreen ingredient for use in the United States. Dermatologists applaud since it offers strong sun protection with fewer real and potential side effects than current chemical sunscreen ingredients.

The agent is bemotrizinol, branded as PARSOL Shield. It can now be used in sunscreen formulas at concentrations up to 6% and carries an FDA safety approval for adults but also for children 6 months of age and older. This agent already has a good track record as it has already been used safely in Europe for decades.

It provides broad-spectrum protection against both UVA and UVB radiation, the types of radiation linked to skin aging, sunburns, and skin cancer. It has several advantages over older chemical sunscreen filters as it causes less skin irritation, remains stable in sunlight longer, and shows lower absorption into the bloodstream compared with existing chemical ingredients.

Better sunscreen options mean better protection, greater comfort, and more people actually using sunscreen regularly. Since about one in every five Americans will develop skin cancer during their lifetime, improvements in sunscreen technology have a real impact on public health.

The references for this report are available on my website.

#Sunscreen #SkinCancerPrevention #Dermatology #SunSafety #HealthNews